GSTM1 and anemia: Higher Hb in both interventions groups vs. control (DID: +3.6 g/L; +MNP: +4.1 g/L) Lower odds of anemia at endline in intervention groups (aOR: 0.52, 95% CI: 0.25, 1.12; +MNP: 0.69, 0.35, 1.36) vs. control